HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chong Jin Kim Selected Research

Glucose (Dextrose)

11/2015Clinical influence of early follow-up glycosylated hemoglobin levels on cardiovascular outcomes in diabetic patients with ST-segment elevation myocardial infarction after coronary reperfusion.
8/2014Hypoglycemia at admission in patients with acute myocardial infarction predicts a higher 30-day mortality in patients with poorly controlled type 2 diabetes than in well-controlled patients.
7/2014One-year clinical impact of cardiac arrest in patients with first onset acute ST-segment elevation myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chong Jin Kim Research Topics

Disease

74Myocardial Infarction
11/2021 - 03/2008
42Cardiovascular Diseases (Cardiovascular Disease)
11/2021 - 03/2008
33ST Elevation Myocardial Infarction
03/2020 - 09/2008
18Death (Near-Death Experience)
11/2021 - 05/2009
16Thrombosis (Thrombus)
10/2021 - 03/2008
12Non-ST Elevated Myocardial Infarction
03/2019 - 09/2008
10Hemorrhage
03/2022 - 05/2009
6Cardiogenic Shock
03/2020 - 01/2013
5Heart Failure
11/2021 - 11/2010
4Left Ventricular Dysfunction
11/2021 - 06/2010
4Coronary Artery Disease (Coronary Atherosclerosis)
11/2015 - 12/2011
4Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2015 - 01/2011
4Chronic Renal Insufficiency
10/2014 - 12/2012
3Pathologic Constriction (Stenosis)
10/2021 - 01/2013
3Type 2 Diabetes Mellitus (MODY)
09/2021 - 08/2014
3Acute Coronary Syndrome
01/2020 - 11/2010
3Infarction (Infarctions)
12/2019 - 04/2011
3Heart Arrest (Cardiac Arrest)
11/2019 - 07/2014
3Hypertension (High Blood Pressure)
03/2019 - 04/2011
3Renal Insufficiency (Renal Failure)
05/2013 - 10/2011
2Ischemic Stroke
02/2020 - 01/2020
2Diabetes Mellitus
01/2018 - 05/2012
2Inflammation (Inflammations)
05/2013 - 03/2012
2Overweight
03/2012 - 11/2010
1Rupture
02/2021
1Atherosclerotic Plaque (Atheroma)
01/2021
1AIDS-Related Complex (ARC)
01/2021
1Hypertriglyceridemia
01/2021
1Hemorrhagic Stroke
09/2019
1Stroke (Strokes)
03/2019
1Chest Pain (Chest Pains)
01/2019
1Tachycardia (Tachyarrhythmias)
01/2019
1MINOCA
01/2019
1Hyperglycemia
01/2019
1Spasm (Spasms)
01/2016
1Coronary Disease (Coronary Heart Disease)
05/2015
1Mitral Valve Insufficiency (Mitral Regurgitation)
10/2013
1No-Reflow Phenomenon
01/2013
1Atherosclerosis
03/2012

Drug/Important Bio-Agent (IBA)

37omega-Chloroacetophenone (Mace)IBA
11/2021 - 03/2008
16Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2021 - 06/2010
9zotarolimusIBA
01/2019 - 03/2010
8Clopidogrel (Plavix)FDA Link
03/2022 - 02/2011
8EverolimusFDA Link
01/2020 - 09/2012
6LDL CholesterolIBA
01/2021 - 10/2010
5CreatinineIBA
03/2020 - 06/2010
5Sirolimus (Rapamycin)FDA Link
10/2014 - 03/2010
4Glycoproteins (Glycoprotein)IBA
10/2016 - 01/2012
4Paclitaxel (Taxol)FDA LinkGeneric
10/2014 - 01/2011
4C-Reactive ProteinIBA
01/2014 - 04/2011
3Pharmaceutical PreparationsIBA
02/2020 - 12/2014
3oxidized low density lipoproteinIBA
09/2019 - 10/2011
3TicagrelorIBA
03/2019 - 11/2018
3HDL CholesterolIBA
05/2016 - 07/2014
3Glucose (Dextrose)FDA LinkGeneric
11/2015 - 07/2014
3MetalsIBA
12/2014 - 04/2011
3Angiotensin Receptor AntagonistsIBA
12/2014 - 06/2010
3CholesterolIBA
10/2010 - 06/2010
2LipidsIBA
10/2021 - 01/2021
2Atorvastatin (Lipitor)FDA Link
01/2021 - 01/2018
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2020 - 09/2012
22'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
02/2020 - 01/2020
2LDL Lipoproteins (beta Lipoproteins)IBA
09/2019 - 10/2010
2Prasugrel HydrochlorideFDA Link
03/2019 - 01/2019
2Heparin (Liquaemin)FDA LinkGeneric
10/2016 - 04/2010
2Angiotensin II Type 1 Receptor BlockersIBA
03/2016 - 01/2014
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
09/2012 - 06/2010
2Platelet Membrane Glycoprotein IIbIBA
05/2012 - 01/2012
2pro-brain natriuretic peptide (1-76)IBA
04/2011 - 11/2010
2Brain Natriuretic Peptide (Natrecor)FDA Link
04/2011 - 11/2010
1Antihypertensive Agents (Antihypertensives)IBA
09/2021
1CatecholaminesIBA
02/2021
1CalciumIBA
01/2021
1Fatty Acids (Saturated Fatty Acids)IBA
01/2021
1Triglycerides (Triacylglycerol)IBA
01/2021
1PolymersIBA
01/2020
1pitavastatin (itavastatin)FDA Link
01/2018
1Simvastatin (Zocor)FDA LinkGeneric
12/2016
1Ezetimibe (Zetia)FDA Link
12/2016
1TroponinIBA
10/2016
1NitratesIBA
10/2016
1boldenone undecylenate (Equipoise)IBA
01/2016
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
11/2015
1Hemoglobins (Hemoglobin)IBA
08/2014
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
09/2012
1Abciximab (ReoPro)FDA Link
01/2012
1Biomarkers (Surrogate Marker)IBA
07/2011
1MB Form Creatine KinaseIBA
04/2011

Therapy/Procedure

54Percutaneous Coronary Intervention
03/2020 - 03/2008
22Stents
02/2020 - 03/2008
19Therapeutics
11/2021 - 06/2009
17Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2018 - 05/2009
16Drug-Eluting Stents
01/2020 - 03/2008
2Length of Stay
10/2016 - 11/2008
1Drug Therapy (Chemotherapy)
10/2020
1Time-to-Treatment
01/2017
1Cardiopulmonary Resuscitation (CPR)
01/2016
1Secondary Prevention
02/2013
1Artificial Respiration (Mechanical Ventilation)
01/2013
1Dual Anti-Platelet Therapy
01/2013